Risk and responsibility
Subtitle: the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005
Publisher: U.S. G.P.O.; For sale by the Supt. of Docs., U.S. G.P.O.
Published: 2005
Place of publication: Washington
Language: eng
Number of pages: 140
Subjects: Nonsteroidal anti-inflammatory agents -- United States -- Testing; Nonsteroidal anti-inflammatory agents -- Safety regulations -- United States; Drugs -- United States -- Testing; Drugs -- Safety regulations -- United States
Notes: Distributed to some depository libraries in microfiche

Shipping list no. not available

Printed record lacks prepared statement of Rep. Charles W. Dent

"Serial no. 109-27."

Includes bibliographical references

Also available via Internet from the GPO Access web site. Addresses as of 8/25/05: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109%5Fhouse%5Fhearings&docid=f:21483.pdf, http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109%5Fhouse%5Fhearings&docid=f:22684.pdf (errata); current access available via PURLs